Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating extracorporeal photopheresis to sustain symptom remission during steroid withdrawal in steroid-dependent Crohn's disease; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Crohn Disease | Phase 1 | Status: COMPLETED